Up-regulated pyrimidine nucleoside phosphorylase in breast carcinoma correlates with lymph node metastasis

K. Mimori, H. Ueo, C. Shirasaka, T. Shiraishi, M. Yamagata, M. Haraguchi, M. Mori

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: The clinical significance of pyrimidine nucleoside phosphorylase (PyNPase) activity in breast carcinomas has never been determined. Materials and methods: In 41 cases of breast carcinoma, the enzyme activity of PyNPase was determined by the high performance liquid chromatography (HPLC) assay and its value was analyzed with clinicopathologic variables. The expression level of mRNA was examined by the semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) assay and compared with the enzyme activity. Results: The higher activity of PyNPase was significantly correlated not only with the presence of vascular permeation (P = 0.02) but of lymph node metastasis (P = 0.02). The mRNA expression correlated well with the enzyme activity (r = 0.74, P < 0.01). A multivariate analysis disclosed the PyNPase factor to be associated with lymph node metastasis. In addition, 17 (41%) showed positive staining only in the tumor stromal cells and 18 (44%) cases showed positive staining in both the tumor stromal cells and the carcinoma cells by immunohistochemical study. Conclusions: These findings suggest that PyNPase activity is a new marker predicting the malignant potential of breast carcinomas, especially with respect to lymph node metastasis, and that the RT-PCR assay is a more useful method than direct evaluation of PyNPase activity.

Original languageEnglish
Pages (from-to)111-113
Number of pages3
JournalAnnals of Oncology
Volume10
Issue number1
DOIs
Publication statusPublished - Mar 1 1999

Fingerprint

Pyrimidine Phosphorylases
Lymph Nodes
Breast Neoplasms
Neoplasm Metastasis
Stromal Cells
Reverse Transcriptase Polymerase Chain Reaction
Enzymes
Staining and Labeling
Messenger RNA
Blood Vessels
Neoplasms
Multivariate Analysis
High Pressure Liquid Chromatography
Carcinoma

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this

Up-regulated pyrimidine nucleoside phosphorylase in breast carcinoma correlates with lymph node metastasis. / Mimori, K.; Ueo, H.; Shirasaka, C.; Shiraishi, T.; Yamagata, M.; Haraguchi, M.; Mori, M.

In: Annals of Oncology, Vol. 10, No. 1, 01.03.1999, p. 111-113.

Research output: Contribution to journalArticle

Mimori, K. ; Ueo, H. ; Shirasaka, C. ; Shiraishi, T. ; Yamagata, M. ; Haraguchi, M. ; Mori, M. / Up-regulated pyrimidine nucleoside phosphorylase in breast carcinoma correlates with lymph node metastasis. In: Annals of Oncology. 1999 ; Vol. 10, No. 1. pp. 111-113.
@article{136d7c669b264c1cb8ae55a958a42edb,
title = "Up-regulated pyrimidine nucleoside phosphorylase in breast carcinoma correlates with lymph node metastasis",
abstract = "Background: The clinical significance of pyrimidine nucleoside phosphorylase (PyNPase) activity in breast carcinomas has never been determined. Materials and methods: In 41 cases of breast carcinoma, the enzyme activity of PyNPase was determined by the high performance liquid chromatography (HPLC) assay and its value was analyzed with clinicopathologic variables. The expression level of mRNA was examined by the semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) assay and compared with the enzyme activity. Results: The higher activity of PyNPase was significantly correlated not only with the presence of vascular permeation (P = 0.02) but of lymph node metastasis (P = 0.02). The mRNA expression correlated well with the enzyme activity (r = 0.74, P < 0.01). A multivariate analysis disclosed the PyNPase factor to be associated with lymph node metastasis. In addition, 17 (41{\%}) showed positive staining only in the tumor stromal cells and 18 (44{\%}) cases showed positive staining in both the tumor stromal cells and the carcinoma cells by immunohistochemical study. Conclusions: These findings suggest that PyNPase activity is a new marker predicting the malignant potential of breast carcinomas, especially with respect to lymph node metastasis, and that the RT-PCR assay is a more useful method than direct evaluation of PyNPase activity.",
author = "K. Mimori and H. Ueo and C. Shirasaka and T. Shiraishi and M. Yamagata and M. Haraguchi and M. Mori",
year = "1999",
month = "3",
day = "1",
doi = "10.1023/A:1008399306583",
language = "English",
volume = "10",
pages = "111--113",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Up-regulated pyrimidine nucleoside phosphorylase in breast carcinoma correlates with lymph node metastasis

AU - Mimori, K.

AU - Ueo, H.

AU - Shirasaka, C.

AU - Shiraishi, T.

AU - Yamagata, M.

AU - Haraguchi, M.

AU - Mori, M.

PY - 1999/3/1

Y1 - 1999/3/1

N2 - Background: The clinical significance of pyrimidine nucleoside phosphorylase (PyNPase) activity in breast carcinomas has never been determined. Materials and methods: In 41 cases of breast carcinoma, the enzyme activity of PyNPase was determined by the high performance liquid chromatography (HPLC) assay and its value was analyzed with clinicopathologic variables. The expression level of mRNA was examined by the semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) assay and compared with the enzyme activity. Results: The higher activity of PyNPase was significantly correlated not only with the presence of vascular permeation (P = 0.02) but of lymph node metastasis (P = 0.02). The mRNA expression correlated well with the enzyme activity (r = 0.74, P < 0.01). A multivariate analysis disclosed the PyNPase factor to be associated with lymph node metastasis. In addition, 17 (41%) showed positive staining only in the tumor stromal cells and 18 (44%) cases showed positive staining in both the tumor stromal cells and the carcinoma cells by immunohistochemical study. Conclusions: These findings suggest that PyNPase activity is a new marker predicting the malignant potential of breast carcinomas, especially with respect to lymph node metastasis, and that the RT-PCR assay is a more useful method than direct evaluation of PyNPase activity.

AB - Background: The clinical significance of pyrimidine nucleoside phosphorylase (PyNPase) activity in breast carcinomas has never been determined. Materials and methods: In 41 cases of breast carcinoma, the enzyme activity of PyNPase was determined by the high performance liquid chromatography (HPLC) assay and its value was analyzed with clinicopathologic variables. The expression level of mRNA was examined by the semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) assay and compared with the enzyme activity. Results: The higher activity of PyNPase was significantly correlated not only with the presence of vascular permeation (P = 0.02) but of lymph node metastasis (P = 0.02). The mRNA expression correlated well with the enzyme activity (r = 0.74, P < 0.01). A multivariate analysis disclosed the PyNPase factor to be associated with lymph node metastasis. In addition, 17 (41%) showed positive staining only in the tumor stromal cells and 18 (44%) cases showed positive staining in both the tumor stromal cells and the carcinoma cells by immunohistochemical study. Conclusions: These findings suggest that PyNPase activity is a new marker predicting the malignant potential of breast carcinomas, especially with respect to lymph node metastasis, and that the RT-PCR assay is a more useful method than direct evaluation of PyNPase activity.

UR - http://www.scopus.com/inward/record.url?scp=0033061591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033061591&partnerID=8YFLogxK

U2 - 10.1023/A:1008399306583

DO - 10.1023/A:1008399306583

M3 - Article

C2 - 10076730

AN - SCOPUS:0033061591

VL - 10

SP - 111

EP - 113

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 1

ER -